NCT07349641 2026-03-17A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial CancerNational Cancer Institute (NCI)Phase 2 Not yet recruiting55 enrolled